MicroGen DX

Call Directions Website Contact the business

MicroGen DX Next-Gen DNA Sequencing for accurate microbial identification

10/14/2026

You did the treatment. You followed the plan. And the pain is still there.

That can be exhausting. ProstateKEY by MicroGenDX tests for over 60,000 bacteria and fungi using their DNA, giving your provider more to go on when deciding what comes next.

Don't just push through it.
Get real answers to move your care forward: https://patients.microgendx.com/products/prostate-test-service

10/13/2026

Some chronic infections don't just attack...they can defend themselves.
They build fortresses called biofilms that hide the source of your symptoms, making them harder to treat 🏰
The path to recovery starts with one step: Finding out what's inside.

DNA testing can help by uncovering over 60,000 potential pathogens with 99.2% accuracy.
Learn more about how biofilms drive chronic illness: https://patients.microgendx.com/blogs/blog/understanding-biofilms-in-chronic-illness-the-hidden-culprits



Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC2920928/

Nothing grew. That doesn’t mean nothing was there.We’ll be at IDWeek 2026 in Washington, DC, October 21-24. Come find us...
10/12/2026

Nothing grew. That doesn’t mean nothing was there.

We’ll be at IDWeek 2026 in Washington, DC, October 21-24. Come find us at Booth 1634.

Culture-negative results are a daily problem in infectious disease. Up to 30% of infective endocarditis cases yield negative blood cultures, according to the American Heart Association. Those patients are not uninfected. Nothing grew under the conditions applied, which is not the same as sterile.

Swipe through for what sequencing recovered where culture did not, from heart valves, from bronchoalveolar lavage, and from more than 2,000 synovial fluid specimens.

MicroGenDX runs qPCR and next-generation sequencing (NGS) as a single integrated test, with results in about 24 hours from sample receipt.

Bring us your hardest cases. Booth 1634.

CAP-accredited · CLIA-certified · CLEP-permitted (NYS DOH)

A clear report means your provider doesn't have to start from guesswork. Deidra's experience reflects what a MicroGenDX ...
10/11/2026

A clear report means your provider doesn't have to start from guesswork. Deidra's experience reflects what a MicroGenDX report is built to deliver: detailed results your doctor can use with confidence.

Every NGS report includes a list of potential treatment options, built from the latest clinical research, giving providers, like Deidra's, a helping hand to pursue precision care.

Thank you for sharing your story, Deidra!
Have you used MicroGenDX testing before?
Tell us about it: https://loom.ly/H7DubtE

No one with chronic illness needs to face it alone. The exhaustion, uncertainty, and experience of chronic symptoms can ...
10/10/2026

No one with chronic illness needs to face it alone. The exhaustion, uncertainty, and experience of chronic symptoms can be too much for any one person to navigate alone.

We've worked with thousands of people navigating complex, hard-to-diagnose infections, and we see the toll it takes — on the body, and on the mind.

This World Mental Health Day, we want you to know: your experience is real, and you're not alone in it.

If you're struggling, reaching out to a mental health professional or a trusted person in your life is a sign of strength, not weakness.

Follow us to learn more about chronic illness and how better answers can support better care.

The MicroGenDX team is thanking primary care providers for their hard work and daily contributions to patient care. They...
10/09/2026

The MicroGenDX team is thanking primary care providers for their hard work and daily contributions to patient care.

They're often on the front line of healthcare, especially when symptoms won't resolve and patients have questions. Happy National Primary Care Week!

Providers, we're also here to support your investigations into complex infections. We have a physician-centric guide to MicroGenDX reporting: https://microgendx.com/the-clinicians-guide-to-the-genomic-galaxy/

…and you can request a free physician peer consult to navigate complex patient cases: https://microgendx.com/speak-to-a-peer-physician/

10/08/2026

Your lungs are working hard for you every day, in about 23,000 breaths 🫁

October is Healthy Lung Month, and a few regular habits go a long way toward keeping them healthy:

✔️ Keep your home smoke-free
✔️ Check and replace your air filters regularly
✔️ Stay physically active

But sometimes a respiratory infection overstays its welcome.

If symptoms persist longer than expected, NGS testing can help identify the pathogens behind it, so you and your provider have real answers to work with.

Breathe easy with MicroGenDX. Learn more about our RespiKEY test: https://patients.microgendx.com/products/respiratory-tract-infection-rti-test-service

LinkedIn🦴 61 of 132 patients with confirmed periprosthetic joint infection had already started antibiotics before they w...
10/07/2026

LinkedIn

🦴 61 of 132 patients with confirmed periprosthetic joint infection had already started antibiotics before they were worked up. Culture came back negative in 36.0% of them, against 18.3% of those who had not.

Antibiotics do not make the organism leave. They make it stop growing. Culture needs it to grow. Next-generation sequencing (NGS) reads DNA, which does not care whether the organism is still viable.

Presented at Joint EBJIS-MSIS 2026 in Porto last month, Mathis et al. looked at 132 MSIS-confirmed PJI cases, 46% of them antibiotic-exposed:

✅ NGS sensitivity 96.2% against culture 73.5%, p=0.001
✅ NGS was positive in 95.1% of the antibiotic-exposed group and 97.2% of the unexposed group. The gap is inside the noise
✅ Culture negativity doubled with prior antibiotics, 36.0% against 18.3%

The same effect is on record in cardiac surgery, and there it is peer-reviewed. Halavaara et al. followed 87 patients to valve surgery for infective endocarditis. In those treated for two weeks or longer before surgery, every single valve culture was negative. 16S rRNA PCR still found the organism in 53%.

Two specialties, two specimen types, one mechanism.

Have a culture-negative case to talk through? Our free peer-to-peer consult connects you with a physician in your specialty who is experienced with MicroGenDX testing.

Request a free peer consult: https://microgendx.com/speak-to-a-peer-physician/

For healthcare professionals. Mathis K, Patel S, Freedhand A, Shahi A, presented at Joint EBJIS-MSIS 2026, Porto, 17-19 September 2026. A conference abstract is not a peer-reviewed publication. Halavaara M et al. Eur J Clin Microbiol Infect Dis. 2019;38(3):497-503, which measured 16S rRNA PCR. Image generated with AI.

The second pan-resistant Candidozyma (Candida) auris case has been documented worldwide.¹What the study found:• An isola...
10/06/2026

The second pan-resistant Candidozyma (Candida) auris case has been documented worldwide.¹

What the study found:
• An isolate from Kenya resisted all four major antifungal classes: azoles, echinocandins, polyenes and flucytosine¹
• It came from a hospital-acquired surgical site infection in a 28-year-old patient¹
• Resistance was identified by culture-based susceptibility testing (VITEK 2) and whole-genome sequencing of the cultured isolate¹
• It is the first pan-resistant case reported outside the US; the only earlier case was in New York in 2022¹

Why it matters for infection control:
• C. auris is a WHO high-priority fungal pathogen that persists on surfaces and spreads between patients in healthcare facilities¹ ³
• Fast identification triggers isolation and infection-control measures, and culture-based susceptibility testing guides treatment³
• MicroGenDX identifies bacteria and fungi, with results within ~24 hours from sample receipt²

Read the full study: https://doi.org/10.1038/s41598-026-70653-9

How is your facility approaching C. auris screening today?

Image: AI-generated scientific illustration.



References
1. Odoyo E, Kigen C, Wachira J, et al. Emergence of pan-drug resistant Candidozyma auris in Kenya, the second globally documented case. Sci Rep. 2026. https://doi.org/10.1038/s41598-026-70653-9
2. MicroGenDX data on file.
3. Centers for Disease Control and Prevention. C. auris for Healthcare and Laboratory Professionals. https://www.cdc.gov/candida-auris/hcp/index.html. Accessed October 2026.

What’s seen under the microscope, missed by culture, yet still causes sinus infection? 🔬🧫Fungal balls. These clumps of f...
10/05/2026

What’s seen under the microscope, missed by culture, yet still causes sinus infection? 🔬🧫

Fungal balls. These clumps of fungus grow inside a sinus cavity, and can cause chronic sinus infection symptoms like facial pressure, congestion, and discharge.

To better detect them, researchers studied 45 sinus samples (38 fungal balls) using microscopy, culture, and DNA sequencing.

They found:
🔬 Microscopy spotted fungus in 97.3% of samples but couldn't say which one it was.
🧫 Culture grew fungus in less than a third of samples.
🧬 DNA sequencing identified fungi in every case and even found bacteria living alongside the fungi in some samples!

MicroGenDX's NGS testing goes further, identifying bacteria and fungi at the species level for clearer answers and care.

If you're dealing with chronic sinus issues, consider our SinusKEY testing: https://loom.ly/J8-1BrI

Study: Dellière et al., Journal of Fungi, 2021 (peer-reviewed). https://loom.ly/g6UdkAc

Address

5776 Hoffner Avenue S
Orlando, FL
32822

Opening Hours

Monday 9am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 9am - 6am

Telephone

+18552080019

Website

,

Alerts

Be the first to know and let us send you an email when MicroGen DX posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MicroGen DX:

Shortcuts

Share